A Practical Approach to Super Refractory Status Epilepticus in Pediatric Intensive Care Unit


Soydan E., Gonullu A., Aksoy Y., Guzin Y., Seven P., ÇOLAK M., ...Daha Fazla

JOURNAL OF DR BEHCET UZ CHILDRENS HOSPITAL, cilt.13, sa.2, ss.130-138, 2023 (ESCI, TRDizin)

Özet

Objective: In this study, we aimed to evaluate the demographic, clinical features, long-term electroencephalography (EEG) findings and treatment modalities of pediatric patients with super refractory status epilepticus (SRSE). Method: A retrospective, observational study was conducted in patients diagnosed as SRSE between 1 June 2018 and 30 May 2021 in the pediatric intensive care unit. Patients with SRSE between 1 month and 18 years of age who underwent continuous electroencephalogram (cEEG) monitoring were included in the study. Demographic data, clinical, and electroencephalographic characteristics were collected. Results: A total of 11 patients were included in the study. The median age of the patients was 31 months (IQR 8-72 months). Nine (81. 8%) patients had symptomatic etiology. Of the symptomatic etiologies, 4 (36. 3%) patients had acute symptomatic, 3 (27. 2%) patients had remote symptomatic and 2 (18. 2%) patients had progressive etiology. The most common etiology was immune-related. The median cEEG duration of the patients was 60 hours (IQR 52-72 hours). Midazolam infusion was given to 11 (100%) patients, ketamine infusion was given to 9 (81. 8%) patients, thiopental infusion was given to 6 (54. 5%) patients, and propofol infusion was given to 2 (18. 1%) patients as coma induction treatment. Intravenous immunoglobulin, corticosteroid and plasmapheresis were administered to 3 (27. 2%) patients with immune etiology. The overall mortality was 18.1%. Conclusion: SRSE is a neurological emergency with high mortality and morbidity. cEEG monitoring is very important in diagnosis and treatment. Immune etiology should be considered in long-lasting seizures, especially if they are resistant to anesthetics. The immunomodulatory therapy should be started.